Patents by Inventor Hans De Nobel

Hans De Nobel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9084734
    Abstract: The present invention provides peptides and supported peptides for treating various diseases and conditions. In particularly preferred embodiments, the present invention provides compositions and methods for personal care. In some embodiments the present invention provides compositions for use in skin and/or hair care, as well as cosmetic compositions. IN alternative particularly preferred embodiments, the present invention provides peptides and supported peptides for treating diseases of the skin, such as rosacea. In some particularly preferred embodiments, the supported peptides of the present invention are anti-VEGF peptides. In alternative particularly preferred embodiments, the anti-VEGF peptides are expressed on a scaffold protein. In some most preferred embodiments, the scaffold protein comprises BBI.
    Type: Grant
    Filed: April 25, 2006
    Date of Patent: July 21, 2015
    Assignee: Danisco US Inc.
    Inventors: Katherine D. Collier, Anthony Day, Hans de Nobel, David A. Estell, Grant C. Ganshaw, Marc Kolkman, Raj Lad, Jeffrey V. Miller, Christopher J. Murray, Scott D. Power, Brian Schmidt, Anita van Kimmenade, Gudrun Vogtentanz
  • Publication number: 20120014885
    Abstract: The present invention provides peptides and supported peptides for treating various diseases and conditions. In particularly preferred embodiments, the present invention provides compositions and methods for personal care. In some embodiments, the present invention provides compositions for use in skin and/or hair care, as well as cosmetic compositions. In alternative particularly preferred embodiments, the present invention provides peptides and supported peptides for treating diseases of the skin, such as rosacea. In some particularly preferred embodiments, the supported peptides of the present invention are anti-VEGF peptides. In alternative particularly preferred embodiments, the anti-VEGF peptides are expressed on a scaffold protein. In some most preferred embodiments, the scaffold protein comprises BBI.
    Type: Application
    Filed: April 25, 2006
    Publication date: January 19, 2012
    Inventors: Katherine D. Collier, Anthony Day, Hans de Nobel, David A. Estell, Grant C. Ganshaw, Marc Kolkman, Raj Lad, Jeffrey V. Miller, Christopher J. Murray, Scott D. Power, Brian Schmidt, Anita Van Kimmenade, Gudrun Vogtentanz
  • Patent number: 7696173
    Abstract: The present invention provides compositions and methods related to expression of protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the protease inhibitors.
    Type: Grant
    Filed: July 14, 2008
    Date of Patent: April 13, 2010
    Assignee: Danisco US Inc.
    Inventors: Katherine Collier, Grant Ganshaw, Hans De Nobel, Scott D. Power, Anita Van Kimmenade, Marc Kolkman, Jeffrey Miller, Brian Schmidt, Gudrun Vogtentanz, David Estell
  • Patent number: 7592420
    Abstract: Described herein are protease inhibitors, variants thereof and methods for their production.
    Type: Grant
    Filed: August 30, 2007
    Date of Patent: September 22, 2009
    Assignee: Genencor International, Inc.
    Inventors: Hans De Nobel, David A. Estell, Wei Liu, Scott D. Power, Brian Schmidt, Huaming Wang
  • Patent number: 7592157
    Abstract: Described herein are protease inhibitors, variants thereof and methods for their production.
    Type: Grant
    Filed: August 30, 2007
    Date of Patent: September 22, 2009
    Assignee: Genencor International, Inc.
    Inventors: Hans De Nobel, David A. Estell, Wei Liu, Scott D. Power, Brian Schmidt, Huaming Wang
  • Publication number: 20090111160
    Abstract: The present invention provides compositions and methods related to expression of protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the protease inhibitors.
    Type: Application
    Filed: July 14, 2008
    Publication date: April 30, 2009
    Inventors: Katherine Collier, Grant Ganshaw, Hans De Nobel, Scott D. Power, Anita Van Kimmenade, Marc Kolkman, Jeffrey Miller, Brian Schmidt, Gudrun Vogtentanz, David Estell
  • Publication number: 20080293607
    Abstract: Disclosed are variants of the ?-amylase derived from Bacillus sp. no. 707, compositions comprising said variants, compositions comprising the variants, and methods of using the variants. The methods of use include methods of cleaning surfaces, laundering textiles, desizing, hydrolyzing biofilms off various substrates, and treating starch (e.g., liquefaction and saccharification).
    Type: Application
    Filed: March 4, 2008
    Publication date: November 27, 2008
    Inventors: Brian E. Jones, Casper Vroemen, Claudine Chang, Corey Naab, Hans De Nobel, Marc Kolkman, Walter Weyler
  • Publication number: 20080234465
    Abstract: Described herein are protease inhibitors, variants thereof and methods for their production.
    Type: Application
    Filed: August 30, 2007
    Publication date: September 25, 2008
    Inventors: Hans De Nobel, David A. Estell, Wei Liu, Scott D. Power, Brian Schmidt, Huaming Wang
  • Patent number: 7413877
    Abstract: The present invention provides compositions and methods related to the expression of Bowman-Birk protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the Bowman-Birk protease inhibitors.
    Type: Grant
    Filed: November 8, 2004
    Date of Patent: August 19, 2008
    Assignee: Genencor International, Inc.
    Inventors: Katherine Collier, Grant Ganshaw, Hans De Nobel, Scott D. Power, Anita Van Kimmenade, Marc Kolkman, Jeffrey Miller, Brian Schmidt, Gudrun Vogtentanz, David Estell
  • Publication number: 20080131932
    Abstract: Described herein are protease inhibitors, variants thereof and methods for their production.
    Type: Application
    Filed: August 30, 2007
    Publication date: June 5, 2008
    Inventors: Hans De Nobel, David A. Estell, Wei Liu, Scott D. Power, Brian Schmidt, Huaming Wang
  • Patent number: 7279564
    Abstract: Described herein are protease inhibitors, variants thereof and methods for their production.
    Type: Grant
    Filed: October 22, 2004
    Date of Patent: October 9, 2007
    Assignee: Genencor International, Inc.
    Inventors: Hans De Nobel, David A. Estell, Wei Liu, Scott D. Power, Brian Schmidt, Huaming Wang
  • Publication number: 20050202535
    Abstract: The present invention provides compositions and methods related to expression of protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the protease inhibitors.
    Type: Application
    Filed: November 8, 2004
    Publication date: September 15, 2005
    Inventors: Katherine Collier, Grant Ganshaw, Hans De Nobel, Scott Power, Anita Van Kimmenade, Marc Kolkman, Jeffrey Miller, Brian Schmidt, Gudrun Vogtentanz, David Estell
  • Publication number: 20050153399
    Abstract: Described herein are protease inhibitors, variants thereof and methods for their production.
    Type: Application
    Filed: October 22, 2004
    Publication date: July 14, 2005
    Inventors: Hans De Nobel, David Estell, Wei Liu, Scott Power, Brian Schmidt, Huaming Wang